|Full Name:||Dr Olivia Dean|
|Position Title:||Research Fellow|
|Telephone:||+61 3 4215 3300|
Dr. Olivia Dean is currently a Research Fellow within the School of Medicine, Deakin University and holds honorary appointments with the Mental Health Research Institute, the Department of Psychiatry, University of Melbourne and Barwon Health.
During her research career, Dr. Dean has been responsible for the development and coordination of several multi-centre, international clinical trials. Dr. Dean's current research interests include both basic and clinical science and centre around developing treatments targeting oxidative biology and inflammation in several psychiatric disorders. She is currently running several clinical trials investigating new therapies, targeting new pathways in depression, bipolar disorder, schizophrenia and autism. This research may not only benefit individuals with these disorders, but will also provide important evidence to better understand the underlying biological factors involved in the development of these disorders.
Now recruiting Honours and PhD students, please email expressions of interest to: firstname.lastname@example.org
Initially focusing on N-acetyl cysteine (NAC) under the supervision of Prof. Michael Berk, Dr. Olivia Dean has assisted in establishing several clinical trials investigating novel therapies for psychiatric illness. Since completing her PhD in 2008, Dr Dean has initiated several new trials investigating completely new therapies for psychiatry, focusing on pathways that have yet to be targeted with conventional psychiatric medications.
Dr. Dean's research has been recognized by several awards, most recently the Lilly Young Investigator Fellow in Bipolar Disorder at the 9th International Conference on Bipolar Disorder. She is currently involved in several professional societies and has reviewed manuscripts for many journals. Dr. Dean is actively supervising four PhD students and is open to supervising both PhD and Honours students interested in novel therapies in psychiatry.
Dr. Dean has published over 30 articles and one book chapter to date and is lead author on nine of these publications. These manuscripts have been published in several high impact factor journals including Trends in Pharmacological Science (impact factor: 10.9), Biological Psychiatry (impact factor: 8.3), Current Medicinal Chemistry (impact factor: 4.8), Journal of Clinical Psychiatry (impact factor: 5.8) and Neuroscience & Biobehavioral Reviews (impact factor: 8.6). Since completing her PhD in 2008, Dr. Dean has received research funding as a lead and associate Chief Investigator from the Brain and Behavior Research Foundation, NHRMC, Simons Foundation, Australasian Society for Bipolar and Depressive Disorders Servier Grant, Australian Rotary Health, Marian and E.H. Flack Trust and the Stanley Medical Research Institute totaling over AU$ 4 million.
Dr Olivia Dean's Publications
- Magalhaes PV, Dean O, Andreazza AC, Berk M, Kapczinski F. Adjuvant antioxidants for bipolar disorder (protocol). Cochrane Database of Systematic Reviews.
- Dean OM, Bush AI, Copolov DL, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M. Effects of N-acetyl cysteine on cognitive function in bipolar disorder. Psychiatry and Clinical Neurosciences. Accepted June 2012
- Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, Kohlmann K, Jeavons S, Hewitt K, Moss K, Allwang C, Schapkaitz I, Cobb H, Buash AI, Dodd S and Malhi GS. Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomised placebo controlled trial. BMC Medicine (Accepted 2 May 2012)